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Background: Different patterns of late gadolinium enhancement (LGE) including mid-wall fibrosis using cardiovascular
magnetic resonance (CMR) have been reported in adult patients presenting with non-ischemic dilated cardiomyopathy
(DCM). In these studies, LGE was associated with pronounced LV remodelling and predicted adverse cardiac outcomes.
Accordingly, the purpose of our study was to determine the presence and patterns of LGE in children and adolescents
with DCM.
Methods: Patients <18 years of age presenting with severe congestive heart failure who were admitted for evaluation
of heart transplantation at our centre underwent CMR examination which consisted of ventricular functional analysis
and assessment of LGE for detection of myocardial fibrosis. Ischemic DCM was excluded by coronary angiography, and
right ventricular endomyocardial biopsies ruled out acute myocarditis.
Results: Thirty-one patients (mean age 2.1 ± 4.2 years) with severe LV dilatation (mean indexed LVEDV 136 ± 48 ml/m2)
and LV dysfunction (mean LV-EF 23 ± 8%) were examined. LGE was detected in 5 of the 31 patients (16%) appearing in
various patterns characterized as mid-wall (n = 1), focal patchy (n = 1), RV insertion site (n = 1) and transmural (n = 2).
Based on histopathological analysis, 4 of the 5 LGE positive patients had lymphocytic myocarditis, whereas one patient
was diagnosed with idiopathic DCM.
Conclusions: In children and adolescents with DCM, focal histologically proven myocardial fibrosis is rarely detected
by LGE CMR despite marked LV dilatation and severely depressed LV function. LGE occurred in various patterns and
mostly in patients with inflammatory cardiomyopathy. It remains unclear whether myocardial fibrosis in childhood
DCM reflects different endogenous repair mechanisms that enable favourable reverse remodelling. Larger trials are
needed to assess the prognostic implications of LGE in childhood DCM.
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Dilated cardiomyopathy (DCM) is the most common
form of cardiomyopathy in children and is characterized
by a dilated and globally hypocontractile left ventricle.
Childhood DCM is a heterogenous disease associated with
high morbidity and mortality [1–3], especially in patients
with idiopathic DCM [4]. Patients frequently develop
severe congestive heart failure. If pharmacological treat-
ment fails, patients are listed for cardiac transplantation
(HTx) or must receive mechanical circulatory support.
However, the clinical course can be variable and some pa-
tients remain stable or even show reverse remodelling
with normalization of LV dimensions and function [5, 6].
Although specific risk factors for adverse outcome have
been found in children with DCM [2, 4, 7, 8], additional
parameters for reliable risk stratification and prediction of
a reverse ventricular remodelling are required to guide
management of these patients.
Cardiovascular magnetic resonance (CMR) has gained
an important role in the diagnosis of patients presenting
with systolic heart failure. Late gadolinium enhancement
(LGE) imaging enables identification and quantifica-
tion of focal macroscopic myocardial fibrosis. In adult
patients with non-ischemic DCM, various studies demon-
strated not only a diagnostic but also prognostic role
of LGE CMR [9–12]. In these studies, different pat-
terns of local myocardial fibrosis including the typical
pattern of “mid-wall” fibrosis assessed by LGE have
been reported in up to 50% of adult patients with
DCM [9–13].
CMR assessment of myocardial fibrosis has been re-
ported to be useful in patients with congenital heart dis-
ease [14, 15] and cardiomyopathies [16], however, data
about LGE imaging in children is limited. The purpose of
our study was to determine whether biopsy-proven myo-
cardial fibrosis can be assessed by LGE in children with
DCM and whether its occurrence is related to the cause
of DCM and in what pattern myocardial fibrosis occurs.
Furthermore, the impact of myocardial fibrosis on reverse
ventricular remodelling should be evaluated.
Methods
Study population
Patients under 18 years of age presenting with congest-
ive heart failure who were admitted for evaluation of
cardiac transplantation at our centre underwent CMR as
part of our routine clinical examination. The diagnosis
of DCM was made according to current guidelines: pa-
tients with a dilated left ventricle, defined by left ventricu-
lar end-diastolic dimension with a z-score of greater than
2 and an ejection fraction below a z-score of -2 were in-
cluded in the study. Patients with congenital cardiac dis-
ease including abnormal origin of the coronary arteries or
Kawasaki disease, neuromuscular or immunologic disease,familial cardiomyopathy, endocrine disorders, metabolic
or mitochondrial disease and clinical evidence of acute
myocarditis (based on the results of the histopathological/
immunohistological analysis of the endomyocardial biop-
sies) were excluded.
Clinical data were retrospectively obtained from hospital
medical records including date of birth, gender, cause of
DCM and age at CMR evaluation. Findings of the CMR
studies were extracted from the routine clinical reports.
Laboratory findings of B-type natriuretic peptide (BNP)
and troponin I (TNI) at initial admission were also
assessed. Clinical follow-up data of the patients included
information about further treatment (i.e. medical heart
failure therapy, pulmonary artery banding, left ventricular
mechanical support, cardiac transplantation) and survival.
Patients who were treated by medical heart failure ther-
apy, follow-up data on echocardiographic data (LV dimen-
sion and function) were also assessed for the evaluation of
reverse ventricular remodelling (defined as normalisation
of LV size and function, i.e. z-score of LVEDD and frac-
tional shortening between +2 to -2 [5]). The study proto-
col was approved by the local ethics committee and all
patients or parents of the patients gave written informed
consent for participation in the study.
Cardiac catheterization protocol, histopathological/
immunohistological analysis of endomyocardial biopsies
and detection of viral genomes
Cardiac catheterization was performed in all patients.
Endomyocardial biopsies were performed in 30 of the 31
patients. In each patient two to three biopsies were taken
from the RV interventricular septum using a transcatheter
bioptome. In one patient there was no myocardial biopsy
available, because myocardial perforation occurred at the
first attempt of biopsy sampling with subsequent need for
emergency surgery.
Histopathological analysis was performed as previously
described [17, 18]. Endomyocardial biopsies were stained
with Masson’s trichrome as well as Giemsa and exam-
ined by light microscopy. Inflammatory cells were quan-
tified with immunohistochemical staining using CD3
(T cells), CD68 (macrophages) and HLA-DR-α to as-
sess HLA class II expression in professional antigen-
presenting immune cells. Nested (RT-) polymerase chain
reaction was performed for the detection of enteroviruses
(including coxsackieviruses group A and B and echovi-
ruses), parvovirus B19 (PVB19), adenoviruses, human
cytomegalovirus, Epstein-Barr virus, and human herpes
virus type 6 (HHV6). The heart was considered to be in-
flamed after immunohistochemical detection of focal or
diffuse mononuclear infiltrates with >14 leukocytes per
1 mm2 (CD3+ T lymphocytes and/or CD68+ macro-
phages) in the myocardium, in addition to enhanced ex-
pression of HLA class II molecules.
Table 1 Patient characteristics
Variable Value
Patients, n 31
Male/Female 14/17
Height, cm 65 (53-161)
Weight, kg 6.6 (3-57)
BSA, m2 0.46 ± 0.33
Age at study, months 7 (1-203)
Age < 4 weeks, n (%) 3 (10)
Age 1-24 months, n (%) 21 (68)
Age 2-12 years, n (%) 5 (16)
Age 12-18 years, n (%) 2 (6)
Cause of DCM
Unknown, n (%) 15 (48)
Chronic lymphocytic myocarditis, n (%) 16 (52)
Detection of virus by endomyocardial biopsy, n (%) 11 (35)
HHV6, n 6
PVB19, n 3
Enteroviruses, n 2
Blood testing
Troponin positive, n (%) 17 (55)
Tropnin, μg/l 0.18 ± 0.28
BNP, pg/ml 1900 ± 2019
NYHA-class, I/II/III/IV, n 0/2/13/16
Medication
ACE-I/ARB, n (%) 24 (77)
Beta-blocker, n (%) 24 (77)
Diuretics, n (%) 27 (87)
Digoxin, n (%) 13 (42)
Antiarrhytmic, n (%) 5 (16)
Inotropcis, n (%) 16 (52)
DCM dilated cardiomyopathy, BSA Body surface area, PVB19 parvovirus B19,
HHV6, human herpes virus type 6, BNP b-type natriuretic peptide, NYHA New
York Heart Association, ACE-I angiotensin-converting inhibitors, ARB angiotensin
receptor blocker; Data are presented as mean standard deviation (SD) or median
and range, as appropriate
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All CMR studies were performed on a 3-T system (Verio,
Siemens, Erlangen, Germany). Images were acquired with
two sixteen-elements phased array coils. Sedation was ap-
plied in most of the patients.
Cine CMR
Images were acquired in supine position with two sixteen-
elements phased array coils. Sedation was applied in youn-
ger patients when considered necessary. The CMR protocol
included a stack of short-axis slices from the base of the
heart to the apex using cine steady-state free precession
(SSFP) with breath-hold or gradient echo (GE) sequences
in free-breathing technique when patients were sedated.
Data acquired during breath-hold were assessed with the
following sequence parameters: TR 48 ms, TE 1.5 ms, flip
angle 60°, slice thickness 6 mm, in plane image resolution
1.3 mm× 1.3 mm× 6.0 mm, temporal resolution 25-40
phases. In measurements during free-breathing, the se-
quence parameters were as follows: TR 56 ms, TE 2.5 ms,
flip angle 12°, slice thickness 5 mm, in plane image reso-
lution 1.4 mm× 1.4 mm× 5.0 mm. End-diastolic (max-
imal) and end-systolic (minimal) volumes, stroke volumes
(SV) and ejection fractions (EF) for the RV and LV were
calculated by dedicated software (ARGUS, Siemens,
Erlangen, Germany) after the RV and LV endocardial bor-
ders were traced manually at end-systole and end-diastole.
All parameters were adjusted to body surface area (BSA).
Late gadolinium enhancement CMR
Before administration of gadolinium, renal function pa-
rameters, i.e. glomerular filtration rate, as well as cre-
atinine levels were assessed to exclude renal dysfunction.
LGE was assessed after intravenous injection of gado-
pentetate dimeglumine (Magnevist, Bayer, Leverkusen,
Germany) at a dose of 0.15 mmol/kg of body weight by
using a two-dimensional inversion-recovery segmented
gradient echo CMR sequence in the cardiac short and
long-axis planes (slice thickness 5 mm, field of view
300 mm). The inversion time was adjusted for optimal
suppression of signal from normal myocardium and the
images were obtained within 5-10 min after injection
(inversion time approximately 250-350 ms). All LGE im-
ages were interpreted accordingly to the American Heart
Association 17-segment model. The patterns of LGE were
classified as subendocardial-based, transmural, mid-wall
striae, mid-wall patchy, subepicardial, RV insertion point
and diffuse. Extent of LGE was assessed using certi-
fied software (cmr42, Circle Cardiovascular Imaging Inc.,
Calgary, Canada).
Statistical analysis
Continuous variables are presented as mean with standard
deviation or median and range, as appropriate. Correlationswere tested using linear regression analysis. Analysis was
performed using GraphPad statistical software package
(San Diego, California, USA). A p value ≤0.05 was consid-
ered statistically significant.
Results
Patient population
Between 01/2009 and 05/2014 thirty-one patients (17 fe-
males, median age 7.0 (1-203) months, median weight
6.6 (3-57) kg) were included in the study. The majority
of patients (n = 21, 68%) were less than one year of age
(Table 1). Associated congenital heart disease included
an atrial septal defect in one patient. On admission, 16
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class III and 2 patients in class II. Mitral valve regurgita-
tion on echocardiography was °1 in 16 patients, °2 in 12
patients and °3 in 3 patients. Mean levels of BNP were
1900 ± 2019 pg/ml and mean TNI levels were 0.18 ±
0.28 μg/l.
Endomyocardial biopsies
According to the results of the histopathological/
immunohistological analysis of the endomyocardial bi-
opsies, 15 patients (48%) revealed DCM without and 16
patients (52%) with inflammation (DCMi, inflammatory
cardiomyopathy) corresponding to the diagnosis of chronic
myocarditis (Table 1). Positive viral genome testing was re-
ported in 11 patients with detection of HHV6 in 6, PVB in
3 and enteroviruses in 2 patients. Histopathological ana-
lysis was not available in one patient (who showed no
signs of acute myocarditis and had negative viral serology
testing).
CMR findings
Mean heart rate at CMR was 115 ± 22 bpm. Mean indexed
(i) LVEDV was 136 ± 48 ml/m2 and mean LVESVi 106 ±
42 ml/m2 resulting in an LVSVi of 30 ± 14 ml/m2 (Table 2).
Mean LV ejection fraction (EF) was 23 ± 8%. Mean
RVEDVi was 65 ± 36 ml/m2, mean RVESVi 36 ± 30 ml/m2
and RVSVi 29 ± 11 ml/m2. Mean RV-EF was 50 ± 13% but
ranging from 12 to 66%.
LGE was detected in 5 of the 31 patients (16%) appearing
in various patterns characterized as focal patchy (1 patient,
aged 12 months with lymphocytic myocarditis), transmural
(2 patients, aged 5 and 7 months, both lymphocytic myo-
carditis), RV insertion fibrosis (1 patient aged 1 month
with lymphocytic myocarditis) and classic ‘mid-wall’Table 2 CMR findings
Variable Value
Heart rate, bpm 115 ± 22
LVEDVi, ml/m2 136 ± 48
LVESVi, ml/m2 106 ± 42
LVSVi, ml/m2 30 ± 14
LVEF, % 23 ± 8
RVEDVi, ml/m2 65 ± 36
RVESVi, ml/m2 36 ± 30
RVSVi, ml/m2 29 ± 11
RVEF, % 50 ± 13
LGE positive, n (%) 5 (16)
LGE, % of LV mass 6.1 ± 5.3
bpm, beats per minute; LV, left ventricle; RV, right ventricle; i, indexed; EDV,
enddiastolic volume; ESV, endsystolic volume; SV, stroke volume;EF, ejection
fraction; LGE, late gadolinium enhancement; Data are presented as mean
standard deviation (SD)(1 patient, aged 16 years, idiopathic DCM) (Figs. 1 and 2).
The mean extent of LGE of moycardial mass was 6.1 ± 5.3%
(range from 1.7 to 14.7%).
Correlations
Levels of troponin I were related to the degree of LV
dysfunction (r = -0.39, p = 0.03) and showed a trend with
increasing LV diameter (r = 0.33, p = 0.07) (Fig. 3). Levels
of B-type natriuretic peptide correlated significantly with
LVEDVi (r = 0.36, p = 0.04) and LVESVi (r = 0.44, p = 0.02)
but not with LV-EF (r = -0.24, p = 0.19). RV parameters
were not related to BNP levels. Significant correlations
were found between LVEDVi and RV-EF (r = -0.44,
p = 0.01), whereas LVEDVi showed no relationship with
RVEDVi (r = 0.20, p = 0.24). No relationship was found be-
tween LV-EF and RV-EF (r = 0.03, p = 0.88).
Follow-up and occurrence of reverse ventricular
remodelling
Of the 26 LGE negative patients 13 underwent pulmon-
ary artery banding (PAB) (Fig. 4) as a rescue therapy
combined with medical heart failure therapy as previ-
ously reported by our group [19]. This intervention was
offered for patients with preserved right ventricular
function and informed consent was obtained from the
parents for this compassionate use treatment. Another 6
patients underwent cardiac transplantation while 7 pa-
tients received only medical heart failure therapy. Of
these latter patients, one patient showed spontaneous re-
verse remodelling, four patients were clinically stable
with unchanged levels of LVEDD values and LV function
while one patient died and another one was lost to
follow-up. Of the five LGE positive patients, none died
or had to undergo mechanical circulatory support. One
of the patients with transmural LGE underwent mitral
valve replacement due to progressive severe mitral valve
insufficiency (probably related to myocardial scarring)
leading to further atrial and ventricular enlargement while
the other patient underwent cardiac transplantation. In
the two other patients (one with focal patchy and one with
RV insertion fibrosis) cardiac dimensions and function
recovered to normal values after 3 and 22 months in-
dicating spontaneous reverse remodelling. The 16 year-
old patient with mid-wall fibrosis declined implantation of
a cardioverter-defibrillator due to episodes of ventricular
tachycardia while clinical status and cardiac dimensions
remained stable.
Discussion
This study demonstrated that in young children and ad-
olescents with dilated cardiomyopathy
(1) The detection of histologically proven focal
myocardial fibrosis by LGE is uncommon (found
Fig. 1 Example of two patients with DCM and no signs of myocardial fibrosis assessed by LGE CMR and the corresponding histopathological and
immunohistochemical findings CMR images of a 6 month-old patient with idiopathic DCM (A-C) and of a 4 month-old patient with DCM with
lymphocytic myocarditis (G-I). Masson’s trichrome staining (D and J) reveals in both patients lesions characterized by interstitial fibrosis (blue) and
the presence of degenerated myocytes. While in the patient with inflammatory cardiomyopathy the number of T lymphocytes (CD3) (K) and
expression of HLA II class molecules on macrophages were increased (L), the uninflamed heart revealed no T cells (E) or enhanced expression of
HLA class II molecules (F)
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and LV function severely depressed,
(2) The majority of LGE positive patients had chronic
myocarditis suggesting a relation between
histological signs of inflammation and LGE,(3) Various patterns of LGE were found with
transmural type of LGE being detected in two of
the 5 patients, which is not typical for non-ischemic
forms of DCM and might reflect embolic
myocardial infarction.
Fig. 2 (See legend on next page.)
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Fig. 2 Results of CMR (left column) and histopathology/immunohistology of the five patients in whom LGE was detected. Various patterns of LGE
were found (transmural LGE in A and E; focal patchy LGE in C; midwall LGE in C; RV insertion LGE in D). The column in the middle shows the
Masson’s trichrome staining illustrating the presence of fibrosis (blue) while the right column displays immunohistochemical analysis reveals
detection of T cells (CD3) or macrophages (CD68). Inflammatory cardiomyopathy was found in four patients (A,B,D,E) whereas the heart of patient
C showed no signs of inflammation
Fig. 3 Relationships between cardiac dimensions (LVEDVi, indexed left ventricular enddiastolic volume) and levels of troponin I (TNI) and B-type
natriuretic peptide (BNP). A significant correlation between left ventricular cardiac dimensions and right ventricular function (RV EF, right ventricular
ejection fraction) was found whereas left and right ventricular function were found to be unrelated
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Fig. 4 Follow-up including outcome and occurrence of reverse
remodelling in the study population. DCM, dilated cardiomyopathy;
LGE, late gadolinium enhancement; MVR, mitral valve replacement; RR,
reverse remodelling; HFT, medical heart failure therapy; HTx, cardiac
transplantation; PAB, pulmonary artery banding; f-up, follow-up
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reported CMR findings in adult patients with non-
ischemic DCM where LGE was detected more frequently
(in up to 50% of patients) and was associated with larger
left ventricles, a higher degree of impaired function, ele-
vated biomarkers and arrhythmias resulting in worse over-
all outcome [9–12, 20]. Accordingly, the presence of focal
LGE in non-ischemic DCM in adults is considered to be
associated with contractile impairment that is thought to
reflect the transition from compensated to decompensated
state representing the endpoint of adverse remodelling
with irreversible ventricular failure [9]. As the severity of
LV dilatation and functional impairment in our study
group was comparable to that reported in series of adult
patients, the low rate of macroscopic fibrosis detected by
LGE in our study is unexpected and the underlying reason
for this finding entirely unknown.
In general, limited data exists about the pathogenesis
of myocardial fibrosis in neonates, children and young
adolescents with all types of cardiomyopathies including
its assessment by LGE [16, 21–23]. Grosse-Wortmann
and colleagues [24] reported 11 children and adolescents
with DCM of various etiologies but found myocardial fi-
brosis by LGE only in one patient. Although the severity
of LV dilatation and dysfunction was more pronounced
in our study group, the prevalence of myocardial fibrosis
by LGE did not increase. Furthermore, as reported by
this group, RV dimensions and function differed widely
among the patients illustrating that childhood DCM can
present as a biventricular disease although no relation-
ship between RV and LV dimensions was detected. How-
ever, the severity of LV dilatation negatively affected RV
function probably due to adverse ventricular-ventricular
interactions while BNP levels were solely related to LV
dimensions.Specific patterns of LGE have been reported in patients
with ischemic and non-ischemic DCM linking the type
of LGE to a certain form of cardiomyopathy. In non-
ischemic DCM mid-wall striae of LGE is known to be
the typical finding, although various patterns such as focal
patchy, subepicardial and diffuse LGE have also been de-
scribed [9–12, 25, 26]. Interestingly, the only patient in
our study with mid-wall LGE had idiopathic DCM and
was the oldest patient in the study cohort (17 years of age)
while a midwall focal patchy pattern of LGE and RV inser-
tion site fibrosis were seen in one patient with lympho-
cytic myocarditis, respectively. It has been described that
myocarditic infiltrations can persist after the acute phase
of myocarditis, but tend to regress over time during heal-
ing [17, 27–29]. Conversely, a transmural pattern of fibro-
sis is not typically for myocarditis or idiopathic DCM,
rather than for ischemic heart disease, but was found in
two patients with myocarditis. These scars could be re-
lated to an embolic event that subsequently caused myo-
cardial infarction or might be associated with interstitial
expansion due to inflammation and/or edema as these pa-
tients were diagnosed for inflammatory cardiomyopathy.
However, discrimination of ischemic from non-ischemic
lesions is crucial in these patients and thus might influ-
ence therapeutic strategy and prognosis.
The underlying mechanisms for the development of fi-
brotic changes in non-ischemic cardiomyopathies are re-
lated to different processes. Myocardial injury can be the
result of different pathogens and toxins causing inflamma-
tion, individual genetic susceptibility, abnormal modulation
of the immune system, permanent adrenergic activation
and metabolic dysregulation [30–32]. Furthermore, in-
creased wall stress due to LV enlargement can lead to
microvascular ischemia with subsequent myocyte necro-
sis which might explain why troponin levels were found to
be related to LV dimension and function in our popula-
tion. The resulting focal areas of replacement fibrosis are
thought to be the basis for the detection of LGE by CMR
although LGE can also be the result of other forms of
interstitial expansion. Although good agreement between
areas of LGE and the pathological location of macroscopic
fibrosis on autopsy has been reported [10, 11], the study
by Schalla and colleagues showed that the presence of
focal LGE in adult DCM patients was more related to
microscopic findings of inflammation rather than fibrosis
in endomyocardial biopsy [33]. This might explain why
the majority (4 of the 5 patients) of our LGE positive pa-
tients were found to have lymphocytic myocarditis. Other-
wise, the low detection rate of LGE in our population
does not imply that myocardial fibrosis is absent in child-
hood DCM. Indeed, only a few histopathological studies
exist about childhood DCM, but those also revealed fibro-
sis as a cardinal feature [34, 35]. This is in accordance with
our findings, where analysis of endomyocardial biopsies
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biopsies, both in patients with and without LGE on CMR.
This suggests that the possible pathogenic factors and
mechanisms leading to the phenotype of LV dilatation
and dysfunction considerably vary in younger patients.
Although speculative, the low incidence of myocardial fi-
brosis assessed by CMR might be related to differences in
myocardial remodelling in DCM between children and
adults. Nishikawa et al. analysed endomyocardial biopsies
and found differences in the distribution of microscopic
patterns of fibrosis, revealing a higher myocarditic index
and a higher incidence of bizarre myocardial hypertrophy
as well as discrete ultrastructural differences between
adults and children with DCM [34, 36] suggesting that
factors and mechanisms causing myocardial damage may
differ between children and adults. Furthermore, differ-
ences in myocardial matrix structure and function [37] as
well as in adrenergic receptor stimulation [38] have been
described, which might have an impact on response to
medical therapy thereby influencing ventricular remodel-
ling and prognosis.
Decision making whether cardiac transplantation is
needed in the individual child with DCM is crucial but is
hampered by a substantial rate of spontaneous recovery of
ventricular dimension and function that has been de-
scribed both in adult and childhood DCM [3, 5, 6, 39, 40].
A recent multicentre study by Everitt et al. demonstrated
a 2-year cumulative incidence of recovery of normal LV
size and function in 22% of patients [5]. One explanation
for this phenomenon might be related to our findings of a
less remodelled myocardium which inherits a higher
chance for recovery. These results can be supported by
the study of Masci et al. who found in adult patients with
idiopathic DCM, that the absence of LGE was a strong
independent predictor of LV reverse remodelling at 2-
years follow-up independent of LV size and function [13].
Nabeta and colleagues recently demonstrated that the es-
timation of fibrosis by baseline CMR-LGE is superior in
predicting reverse remodelling and outcome than the esti-
mation of fibrosis by baseline endomyocardial biopsy [41].
Due to the high number of patients in our study cohort
who underwent pulmonary artery banding or cardiac
transplantation, procedures that affect the natural history
of this disease, only a minority of patients received exclu-
sively medical heart failure therapy not allowing any fur-
ther statistical analysis of the predictive value of LGE in
children with DCM. However, detection of LGE seemed
not to have an impact on the occurrence of reverse re-
modelling or outcome which demonstrates that CMR
LGE may not be able to separate those patients with a
high chance for recovery from those who will be affected
by an aggravation in ventricular function with a subse-
quent higher risk for death and/or cardiac transplant.
Whether myocardial fibrosis in childhood DCM is a factorfor evaluating innovative treatment options also taking ad-
vantage of the suggested preserved cardiac regenerative
capacity of the myocardium of young children will require
further investigations [42–44].
Study limitations
The small study population and the retrospective design
of the study were accompanied by a selection bias towards
patients presenting in an advanced stage of the disease
who were referred for cardiac transplantation might not
represent the entire population of children and adolescents
with DCM. Therefore, the reported incidence of LGE as
well as the observed rate of spontaneous recovery and out-
come might differ in reality.
Compared to previous studies, we observed a higher
incidence of patients with myocarditis which must be
considered when interpreting the data. The reason for this
might be related to the fact that other causes for DCM, es-
pecially hereditary forms, were excluded in order to ana-
lyse a homogenous patients cohort. While the underlying
genetic causes for childhood DCM are increasingly recog-
nized [45], routine genetic testing for mutations known to
cause DCM is not performed at our institution which may
have resulted in a certain selection bias.
Identification of LGE in very young patients may be
limited by respiratory or motion artifacts related to spon-
taneous breathing under sedation. Furthermore, spatial
resolution of the CMR sequence might be too low to de-
tect small areas of local fibrosis in neonates and infants
thereby underestimating its real prevalence. However, in a
previous study in neonates and infants with ischemic
DCM [21], LGE could be reliably assessed. Because no
additional method besides LGE was used to confirm histo-
logically proven areas of myocardial fibrosis thereby po-
tentially missing important signs of adverse ventricular
remodelling. Furthermore, the used LGE technique can-
not detect perivascular and interstitial myocardial fibrosis
that is frequently observed in non-ischemic DCM [46].
Further developments of T1 mapping sequences that en-
able reliable quantification of the extracellular space in
younger patients may potentially provide further and earl-
ier insights into adverse cardiac remodelling in pediatric
heart failure.
Conclusions
In children and adolescents with DCM, focal histologically
proven myocardial fibrosis is rarely detected by LGE CMR
despite marked LV dilatation and severely depressed LV
function. LGE occurred in various patterns and mostly in
patients with inflammatory cardiomyopathy. It remains
unclear whether myocardial fibrosis in childhood DCM
reflects different endogenous repair mechanisms that en-
able favourable reverse remodelling. Despite the small
study population, our findings suggest that LGE may not
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risk stratification as seen in adult patients. Nevertheless,
the observed differences in incidence of myocardial fibro-
sis compared to adult patients may influence the thera-
peutic strategy in childhood DCM taking advantage of a
less remodelled LV.
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